Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology

N. A.Mark Estes, Richard J. Kovacs, Aaron L. Baggish, Robert J. Myerburg

Research output: Contribution to journalArticle

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)2429-2433
Number of pages5
JournalJournal of the American College of Cardiology
Volume66
Issue number21
DOIs
StatePublished - 2015

Keywords

  • ACC/AHA Scientific Statements
  • athletes
  • cardiovascular abnormalities
  • drugs
  • performance-enhancing substances

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this